NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Acorda Therapeutics 

15 Skyline Drive

Hawthorne  New York  10532  U.S.A.
Phone: 914-347-4300 Fax: 914-347-4560


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Athersys, Inc.  A functional genomics collaboration focused on the discovery of validated drug targets to treat certain central nervous system disorders, including spinal cord injuries and multiple sclerosis. Athersys and Acorda will jointly own therapeutic products or validated targets identified and developed through the collaboration.





 Company News
Acorda Therapeutics (ACOR) to Present at the Lazard Capital Markets 6th Annual Healthcare Conference 11/16/2009 8:49:03 AM    More...
Acorda Therapeutics (ACOR) Reports Third Quarter 2009 Financial Results 11/3/2009 8:54:50 AM    More...
Acorda Therapeutics (ACOR) to Host Conference Call to Report Third Quarter 2009 Financial Results on November 3, 2009 10/27/2009 10:01:43 AM    More...
Acorda Therapeutics (ACOR) (JOBS) Announces Extension of Fampridine-SR PDUFA Goal Date to January 22, 2010 10/22/2009 6:49:33 AM    More...
Acorda Therapeutics (ACOR) (JOBS) Announces Positive Vote by FDA Advisory Committee for Fampridine-SR 10/15/2009 6:52:49 AM    More...
Acorda Therapeutics (ACOR) (JOBS) Stock Trading Halted Today; FDA Advisory Committee to Review Fampridine-SR for Improvement of Walking Ability in People with Multiple Sclerosis 10/14/2009 7:34:33 AM    More...
US FDA Staff Says Limited Effect with Acorda Therapeutics (ACOR) (JOBS) MS Drug 10/9/2009 6:58:53 AM    More...
Acorda Therapeutics (ACOR) Announces Data on Retention Rates and Safety from Two Phase 3 Fampridine-SR Extension Studies 9/15/2009 9:40:23 AM    More...
Acorda Therapeutics (ACOR) Announces Interim Analysis of Two-Year Efficacy and Safety Data from Phase 3 Fampridine-SR Extension Study 9/10/2009 10:16:34 AM    More...
Acorda Therapeutics (ACOR) Reports Date of FDA Advisory Committee Review of Fampridine-SR for Improvement of Walking Ability in People with MS 8/25/2009 8:32:49 AM    More...
12345678910...